file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 28778, GCS 156243 Collection span: 1963 - 2008 | |
| Title Word List (6206) Word count: 52420, All words count: 73729 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | HIGH | 45 | 93 | 841 |
| 202 | PRIMARY | 45 | 204 | 2315 |
| 203 | SUCCESSFUL | 45 | 320 | 922 |
| 204 | CONTROL | 44 | 109 | 1151 |
| 205 | DIAGNOSIS | 44 | 197 | 788 |
| 206 | GROWTH | 44 | 153 | 2205 |
| 207 | PATHOGENESIS | 44 | 127 | 1161 |
| 208 | SMALL | 44 | 112 | 804 |
| 209 | SPLEEN | 44 | 250 | 813 |
| 210 | CURRENT | 43 | 189 | 580 |
| 211 | ENDOCRINE | 43 | 195 | 681 |
| 212 | FEMOROPOPLITEAL | 43 | 228 | 1355 |
| 213 | TIME | 43 | 264 | 1053 |
| 214 | ASSESSMENT | 42 | 141 | 913 |
| 215 | OCCLUSIVE | 42 | 228 | 782 |
| 216 | XENOGENEIC | 42 | 201 | 1384 |
| 217 | BALLOON | 41 | 160 | 1869 |
| 218 | GENETIC | 41 | 119 | 673 |
| 219 | INDUCES | 41 | 437 | 1827 |
| 220 | INFLAMMATORY | 41 | 58 | 928 |
| 221 | OPEN | 41 | 160 | 1125 |
| 222 | SITE | 41 | 263 | 564 |
| 223 | ADMINISTRATION | 40 | 163 | 792 |
| 224 | NERVOUS | 40 | 214 | 2189 |
| 225 | RECONSTRUCTION | 40 | 103 | 775 |
| 226 | SYSTEMIC | 40 | 218 | 1265 |
| 227 | THYMIC | 40 | 295 | 1001 |
| 228 | TRANSLUMINAL | 40 | 113 | 806 |
| 229 | TREATED | 40 | 196 | 692 |
| 230 | UNRESPONSIVENESS | 40 | 887 | 1512 |
| # | Word | Recs | TLCS | TGCS |
| 231 | ALPHA | 39 | 92 | 1325 |
| 232 | APPROACH | 39 | 83 | 463 |
| 233 | CD2 | 39 | 251 | 992 |
| 234 | IMMUNOSUPPRESSIVE | 39 | 166 | 1178 |
| 235 | NORMAL | 39 | 142 | 946 |
| 236 | NOVEL | 39 | 131 | 1075 |
| 237 | PORCINE | 39 | 138 | 858 |
| 238 | PROLONGATION | 39 | 379 | 1009 |
| 239 | PRONE | 39 | 344 | 969 |
| 240 | SINGLE | 39 | 219 | 996 |
| 241 | BASED | 38 | 167 | 841 |
| 242 | CORNEAL | 38 | 67 | 725 |
| 243 | DESTRUCTION | 38 | 320 | 1357 |
| 244 | DOGS | 38 | 220 | 904 |
| 245 | IMPLICATIONS | 38 | 120 | 1082 |
| 246 | PROLONGED | 38 | 238 | 906 |
| 247 | SPONTANEOUS | 38 | 642 | 1157 |
| 248 | SPONTANEOUSLY | 38 | 510 | 1082 |
| 249 | VECTOR | 38 | 73 | 1783 |
| 250 | XENOGRAFT | 38 | 230 | 808 |
| 251 | CANINE | 37 | 115 | 561 |
| 252 | DERIVED | 37 | 148 | 1677 |
| 253 | DISEASES | 37 | 93 | 2078 |
| 254 | EYE | 37 | 261 | 1400 |
| 255 | INDUCE | 37 | 221 | 945 |
| 256 | NATURAL | 37 | 244 | 1146 |
| 257 | PROTEIN | 37 | 107 | 1023 |
| 258 | STATUS | 37 | 188 | 699 |
| 259 | ANTERIOR | 36 | 256 | 1062 |
| 260 | COMBINED | 36 | 76 | 493 |
| # | Word | Recs | TLCS | TGCS |
| 261 | DUPLEX | 36 | 130 | 807 |
| 262 | LOCAL | 36 | 115 | 730 |
| 263 | LYMPHOPROLIFERATIVE | 36 | 99 | 1038 |
| 264 | MODELS | 36 | 43 | 587 |
| 265 | SERUM | 36 | 272 | 857 |
| 266 | FEMORAL | 35 | 360 | 747 |
| 267 | FUTURE | 35 | 57 | 771 |
| 268 | IMMUNOLOGY | 35 | 171 | 1287 |
| 269 | INHIBITION | 35 | 96 | 569 |
| 270 | POTENTIAL | 35 | 123 | 836 |
| 271 | PRESSURE | 35 | 274 | 427 |
| 272 | PRODUCTION | 35 | 94 | 533 |
| 273 | PROSPECTIVE | 35 | 269 | 1485 |
| 274 | REGULATORY | 35 | 63 | 631 |
| 275 | RELATED | 35 | 146 | 515 |
| 276 | VITRO | 35 | 49 | 347 |
| 277 | ASPECTS | 34 | 126 | 649 |
| 278 | DIFFERENT | 34 | 113 | 665 |
| 279 | FOLLOW | 34 | 239 | 835 |
| 280 | IMPACT | 34 | 276 | 1273 |
| 281 | LITERATURE | 34 | 103 | 761 |
| 282 | PRESENTING | 34 | 316 | 1013 |
| 283 | SYNDROME | 34 | 160 | 898 |
| 284 | CHAMBER | 33 | 259 | 1080 |
| 285 | MYCOBACTERIUM | 33 | 138 | 640 |
| 286 | RECURRENT | 33 | 221 | 809 |
| 287 | ACTIVITY | 32 | 51 | 508 |
| 288 | APOPTOSIS | 32 | 116 | 1596 |
| 289 | CHARACTERIZATION | 32 | 62 | 940 |
| 290 | DONORS | 32 | 130 | 456 |
| # | Word | Recs | TLCS | TGCS |
| 291 | HEPATIC | 32 | 82 | 373 |
| 292 | ISOLATION | 32 | 148 | 575 |
| 293 | NECROSIS | 32 | 120 | 1571 |
| 294 | STREPTOZOTOCIN | 32 | 64 | 295 |
| 295 | TECHNIQUE | 32 | 99 | 448 |
| 296 | TRANSFUSION | 32 | 109 | 580 |
| 297 | VECTORS | 32 | 67 | 1383 |
| 298 | CULTURED | 31 | 157 | 487 |
| 299 | IMMUNOGENICITY | 31 | 208 | 3824 |
| 300 | INVIVO | 31 | 200 | 2108 |